Uncategorized
Baker McKenzie Acts on the Privatization of Bright Scholar
When Bright Scholar Education Holdings Limited (“Bright Scholar”; NYSE: BEDU) successfully completed a going-private merger with Bright Education Mergersub Limited, a fully owned subsidiary of Excellence Education Investment Limited (“Excellence Education”), Baker McKenzie served as US legal counsel.
Read MoreNorton Rose Fulbright advises lenders on PLN 227 million refinancing of 114 MW solar PV portfolio in Poland
A group of Polish financial institutions, including mBank and Bank Ochronyęrodowiska, have received advice from Norton Rose Fulbright regarding a long-term refinancing facility of PLN 227 million (EUR 53.5 million) given to special purpose vehicles under the control of Atsinaujinančios Energetikos Investicijos, a closed-end investment fund overseen by Lords LB Asset Management.
Read MoreMayer Brown advises Sienna Private Equity on the strategic partnership with Independent Talent Group
Sienna Private Equity (“SPE”) has received advice from Mayer Brown on the strategic alliance with Independent Talent Group Limited (“ITG”), a premier talent agency that represents A-list celebrities and up-and-coming talent in the fields of film, television, theater, literacy, and digital media.
Read MoreHogan Lovells advises Raselli Franco Group on the staged sale of its share capital to Kering
Regarding the agreement for the staged sale of its share capital to Kering S.A., Hogan Lovells has advised Raselli Franco Group, a family-run business known for its proficiency and quality in creating both high jewelry and fine jewelry items for luxury brands.
Read MoreHogan Lovells advises on the issuance of a €5 million minibond listed on Euronext Access Milano by Vezzani
Hogan Lovells served as deal counsel for Vezzani S.p.A.’s issuance and concurrent listing on Euronext Access Milan of a €5 million minibond with a 60-month term and a 12-month amortization period.
Read MoreGibson Dunn Advising Yarrow Bioscience on Merger with VYNE Therapeutics and Concurrent $200 Million Financings
Yarrow Bioscience is receiving advice from Gibson Dunn on its $200 million fundraising and merger with VYNE Therapeutics.
Read MoreGibson Dunn Advised Celanese Corporation on Concurrent $1.4 Billion Senior Notes Offering and $1.2 Billion Tender Offers
Celanese Corporation received advice from Gibson Dunn on its simultaneous $1.4 billion senior notes issuance and $1.2 billion tender offers.
Read MoreNorton Rose Fulbright advises the Council of the City of Gold Coast in Queensland, Australia, on landmark organics business acquisition
Norton Rose Fulbright provides historic organics company purchase advice to the Council of the City of Gold Coast on Queensland, Australia.
Read MoreBaker McKenzie Advises HSBC on Parnell Pharmaceutical’s AUD 110,000,000 Noble Pharma Acquisition Financing
Regarding a AUD 110,000,000 financing given to Parnell Pharmaceuticals Holdings Pty Ltd (“Parnell”), an affiliate of DW Healthcare Partners (“DWHP”), in connection with the purchase of Noble Pharma, LLC (“Noble Pharma”), Baker McKenzie has advised The Hong Kong and Shanghai Banking Corporation Limited as required lead arranger and bookrunner.
Read MoreHogan Lovells advises VIRTUS on its first data centre financing in Germany
Hogan Lovells, under the direction of Dr. Carla Luh and Stipe Bojanić, has provided financial advice to VIRTUS BERLIN1 GmbH and connected businesses regarding the financing of their first data center in Germany.
Read More